Codexis Inc
NASDAQ:CDXS
Codexis Inc
Revenue
Codexis Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Codexis Inc
NASDAQ:CDXS
|
Revenue
$70.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Revenue
$2.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Codexis Inc
Revenue Breakdown
Breakdown by Geography
Codexis Inc
Total Revenue:
70.1m
USD
|
Apac:
33.5m
USD
|
EMEA:
22.9m
USD
|
China:
20.3m
USD
|
Americas:
13.7m
USD
|
United States:
13.7m
USD
|
Switzerland:
11.1m
USD
|
Ireland:
500k
USD
|
Breakdown by Segments
Codexis Inc
See Also
What is Codexis Inc's Revenue?
Revenue
70.1m
USD
Based on the financial report for Dec 31, 2023, Codexis Inc's Revenue amounts to 70.1m USD.
What is Codexis Inc's Revenue growth rate?
Revenue CAGR 10Y
8%
Over the last year, the Revenue growth was -49%. The average annual Revenue growth rates for Codexis Inc have been 1% over the past three years , 3% over the past five years , and 8% over the past ten years .